Hua Medicine

2552.KHK
Developing innovative drugs for diabetes and related metabolic disorders.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Shanghai, China

Initial Investment

2010
Developing innovative drugs for diabetes and related metabolic disorders.

Hua Medicine (2552.KHK) is a leading clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders.